Machine Learning Model Integrating Conventional Ultrasound Radiomics and Clinicopathological Features for Early Recurrence Risk Prediction After Curative-Intent Hepatectomy in Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma · 2026-10 · Volume 13 · 1-17
DOI: 10.2147/jhc.s647092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-10. Verfasst von Xinyue Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, 150081, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, 150081, People's Republic of China.
ORCID-Profile: Xinyue Zhao, Bolin Wu, Yichi Chen, Wen Cheng
Zitieren
APA
Zhao, X., Wu, B., Chen, Y., & Cheng, W. (2026). Machine Learning Model Integrating Conventional Ultrasound Radiomics and Clinicopathological Features for Early Recurrence Risk Prediction After Curative-Intent Hepatectomy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, Volume 13, 1-17. https://doi.org/10.2147/jhc.s647092
Vancouver
Zhao X, Wu B, Chen Y, Cheng W. Machine Learning Model Integrating Conventional Ultrasound Radiomics and Clinicopathological Features for Early Recurrence Risk Prediction After Curative-Intent Hepatectomy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-17. doi:10.2147/jhc.s647092
BibTeX
@article{Zhao2026,
author = {Zhao, Xinyue and Wu, Bolin and Chen, Yichi and Cheng, Wen},
title = {Machine Learning Model Integrating Conventional Ultrasound Radiomics and Clinicopathological Features for Early Recurrence Risk Prediction After Curative-Intent Hepatectomy in Hepatocellular Carcinoma},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--17},
doi = {10.2147/jhc.s647092}
}
EUVIMED